期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乌司他丁对小儿体外循环期间中性粒细胞弹性蛋白酶变化的影响

下载PDF
导出
作者 杨欣玮 郑丽娟 石卓 施姗姗 张向红 沈红强 舒强
机构地区 浙江大学医学院附属儿童医院
出处 《浙江预防医学》 2006年第2期41-42,共2页 Zhejiang Journal of Preventive Medicine
基金 浙江省科技计划项目(2003C33022)
关键词 中性粒细胞弹性蛋白酶 体外循环期间 乌司他丁 缺血一再灌注损伤 小儿 蛋白水解酶抑制剂 全身炎症反应 表面接触 炎症介质 组织器官
分类号 R691.3 [医药卫生—泌尿科学] R654.1 [医药卫生—外科学]
  • 相关文献

参考文献8

  • 1Davies SW, Duffy JP, Wieken DG, etal. Time - curse of free radical activity during coronary artery operation with cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg, 1993. 105 (6): 979-987.
  • 2Anthony LP, Charles JL, Christine F; et al. Multiple sequential insults cause post-pump syndrome [J]. Ann Thorac Surg, 1999, 67 (,4):978 - 985.
  • 3强喆,周丕均,李玉兰,李天成,陈春红.体外循环期间乌司他丁对肺功能的保护作用[J].中华麻醉学杂志,2004,24(1):57-58. 被引量：10
  • 4Hiyama A, Takeda J, Kotate Y, et al. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elasetase during eardiopulmonary bypass [ J]. J Cardiothorac Vase Anesth, 1997, 11: 580-584.
  • 5吉冰洋.体外循环中乌司他丁对机体的保护作用[J].中国胸心血管外科临床杂志,2002,9(1):51-53. 被引量：36
  • 6A Finn, S Naik, N Kleir, et al. Interleukin- 8 release and neutrophil degranulation after pediatric cardiopulmonary bypass [ J ]. J Thorac Cardiovasc Surg, 1993; 105: 234-241.
  • 7李桂芬,孙桂民,高国栋,李景文,杨九光,胡强.乌司他丁对婴幼儿体外循环炎性反应的影响[J].中国体外循环杂志,2003,1(1):13-15. 被引量：13
  • 8Gando S, Tedo I, Increased neutrophil elastase in patients with cardiopulmonary arrest: role of elastase inhabitor [J], Intensive Care Med, 1995, 21 (8): 636-640,.

二级参考文献26

  • 1[1]Sato Y,Ishikawa S,Otaki A,et al.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin.Inhibiting cytokines and postoperative organ injury.Jpn J Thorac Cardiovasc Surg,2000,48(7):428-434.
  • 2[2]Conlon PJ,Stafford-Smith M,White WD,et al.Acute renal failure following cardiac surgery.Nephrol Dial Transplant,1999,14(5):1158-1162.
  • 3[3]Suen WS,Mok CK,Chiu SW,et al.Risk factors for development of acute renal failure(ARF) requiring dialysis in patients undergoing cardiac surgery.Angiology,1998,49(10):789-800.
  • 4[4]Oshima N,Yamada T,Nakahara H,et al.Effect of ulinastatin(UL) on renal function and lactic acidosis during open-heart surgery:comparison with aprotinin.Kyobu Geka,1990,43(5):357-363.
  • 5[5]Ueki M,Yokono S,Nogaya J,et al.Effects of ulinastatin on postoperative renal function after cardiopulmonary bypass.Masui,1995,44(5):691-697.
  • 6[6]Yonoko S,Ueki M,Nakayo M,et al.Urinary excretion of ulinastatin and NAG after cardiopulmonary bypass.Masui,1997,46(3):388-392.
  • 7[7]Ueki M,Yokono S,Komatsu H,et al.The support of postoperative renal function by ulinastatin inpatients with preoperative renal dysfunction.Masui,1995,44(4):570-573.
  • 8[8]Nakakuki M,Yamasaki F,Shinkawa T,et al.Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats.Can J Physiol Pharmacol,1996,74(1):104-111.
  • 9[9]Ueki M,Yokono S,Taie S,et al.Supplement of ulinastatin on renal function after cardiopulmonary bypass.Masui,2000,49(2):163-167.
  • 10[10]Tanita T,Song C,Kubo H,et al.Superoxide anion mediates pulmonary vascular permeability caused by neutrophils in cardiopulmonary bypass.Surg Today,1999,29(8):755-761.

共引文献56

浙江预防医学
2006年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部